Results 131 to 140 of about 29,282 (210)

From Needle to Sachet: Fosfomycin Versus Amikacin for Cystoscopy Prophylaxis. [PDF]

Cureus
Quadir U, Para SA, Malik SA, Hamid A, Khawaja AR, Mehdi S, Arsalan SS, Raina AB, Kannan G, Bhat OM.   +9 more
europepmc   +1 more source

Adjunctive Fosfomycin for the Treatment of Staphylococcus aureus Bacteremia: A Pooled Post Hoc Analysis of Individual Participant Data From 2 Randomized Trials. [PDF]

Clin Infect Dis
Escrihuela-Vidal F, Ong SWX, Oriol I, Grillo S, Pujol M, Pallarès N, Tebé C, Liu K, Miró JM, Tong SYC, Carratalà J.   +10 more
europepmc   +1 more source

Ciprofloxacin Versus Fosfomycin for Empirical Prophylaxis Before Transrectal Prostate Biopsy: Clinical, Microbiological, and Patient-Reported Outcomes from a Prospective Study. [PDF]

Med Sci (Basel)
Burzinskis E, Janulaityte I, Burzinskiene G, Skaudickas D, Naudziunas A, Vitkauskiene A.   +5 more
europepmc   +1 more source

High prevalence of fosfomycin resistance among ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae isolates in a tertiary hospital from Jiangxi Province, South China. [PDF]

Int Microbiol
Li M, Li P, Cui J, Zhu P, Guo H, Zuo W, Liao W.   +6 more
europepmc   +1 more source

Subphenotype- and complication-guided adjunctive fosfomycin versus standard monotherapy in <i>Staphylococcus aureus</i> bacteraemia: pooled analysis of two randomised trials. [PDF]

Lancet Reg Health Eur
Escrihuela-Vidal F, Larrauri JG, López-Contreras J, Euba G, Vázquez A, Gómez-Zorrilla S, López-Cortés LE, Gasch O, Aparicio-Minguijón E, Escudero-Sánchez R, Pérez-Rodríguez MT, Rodríguez-Pardo D, Jover-Sáenz A, García-Pardo G, Rodríguez-Baño J, Pujol M, Carratalà J, Gutiérrez-Gutiérrez B, BACSAFO/FEN-AUREUS Group.   +18 more
europepmc   +1 more source

Fosfomycin Resistance: An Update on the Anthropogenic Impact Through Agriculture. [PDF]

Pathogens
Goraj W, Kowalczyk P, Bełżecki G, Furtak A, Pytlak A, Szafranek-Nakonieczna A.   +5 more
europepmc   +1 more source

Antimicrobial resistance in ESKAPEE pathogens isolated from institutionalized vs. non-institutionalized elderly patients with urinary tract infections: a 5-years study. [PDF]

World J Urol
Ramírez-Vilariño G, Alonso-González I, Lopez-Picado A, Burgos-Alonso N.   +3 more
europepmc   +1 more source

<i>fosZ</i>, a novel plasmid-borne fosfomycin resistance gene in <i>Pseudomonas</i> species, especially carbapenem-resistant <i>Pseudomonas aeruginosa</i> isolates. [PDF]

Antimicrob Agents Chemother
Shao Y, Lan X, Zhang X, Wang L, Yang F, Wang M, Guo Q.   +6 more
europepmc   +1 more source

Fitness cost and biofilm formation in fosfomycin-resistant clinical <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> isolates. [PDF]

Turk J Med Sci
Ökeer M, Aydemir SŞ, Eraç B.
europepmc   +1 more source

Pharmacokinetics and safety of fosfomycin and flomoxef administered as part of neonatal sepsis treatment (NeoSep1 Part 1). [PDF]

Antimicrob Agents Chemother
Bekker A, Panjasawatwong N, Hill LF, Stohr W, Walker AS, Ellis S, Dramowski A, Whitelaw A, Obiero C, Berkley JA, Makazi A, Velaphi S, Thomas R, Magagula P, Abrahams I, Nakwa FL, Barday MM, Van Kwawegen A, Pillay K, Gastine S, Standing JF, Skoutari P, Schiavone F, Sharland M, O'Brien S, Bielicki JA, Cressey TR, NeoSep Study Team.   +27 more
europepmc   +1 more source